Rankings
▼
Calendar
ZTS Q3 2016 Earnings — Zoetis Inc. Revenue & Financial Results | Market Cap Arena
ZTS
Zoetis Inc.
$53B
Q3 2016 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$1.2B
Gross Profit
$812M
65.4% margin
Operating Income
$377M
30.4% margin
Net Income
$239M
19.3% margin
EPS (Diluted)
$0.48
QoQ Revenue Growth
+2.7%
Cash Flow
Operating Cash Flow
$239M
Free Cash Flow
$182M
Stock-Based Comp.
$9M
Balance Sheet
Total Assets
$7.7B
Total Liabilities
$6.1B
Stockholders' Equity
$1.6B
Cash & Equivalents
$651M
Revenue Segments
Dogs and Cats
$457M
37%
Cattle
$432M
35%
Swine
$145M
12%
Poultry
$111M
9%
Horses
$33M
3%
Fish
$25M
2%
Sheep and Other
$22M
2%
Geographic Segments
UNITED STATES
$640M
52%
International
$585M
48%
← FY 2016
All Quarters
Q4 2016 →